Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)
Heng Wan(The First People's Hospital of Shunde), Jie Shen(Xinjiang Medical University), Jing Yang(Hebei Medical University), Huang GuoQiu(The First People's Hospital of Shunde), Lan Liu(Children's Hospital of Chongqing Medical University), Lingling Liu(Nanjing Tech University), Si‐Yang Liu(Sun Yat-sen University), Xiao Wang(Chinese Academy of Agricultural Sciences), Zhao Li(The First People's Hospital of Shunde), Aimin Yang(Hebei Medical University), Nanfang Yao, Xü Lin(First Affiliated Hospital Zhejiang University)
European Heart Journal - Quality of Care and Clinical Outcomes
September 12, 2024
Cited by 9
Related Papers
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
<p>Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes Combined Pluronic F127 Hydrogel Promote Chronic Diabetic Wound Healing and Complete Skin Regeneration</p>
|International Journal of Nanomedicine|2020|521
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
|Diabetes Care|2012|365
The good, the bad, and the ugly of calcium supplementation: a review of calcium intake on human health
|Clinical Interventions in Aging|2018|193